Q2i Wins HealthTech Company of the Year

---

---

Winner in the Corporate LiveWire Global Awards 2025/26

Q2i is a digital health company dedicated to developing, refining, validating and commercialising innovative, evidence-based solutions. Transforming the way digital tools support behavioural health and chronic-disease prevention, the organisation delivers advanced digital health technology that strengthens engagement and measurable outcomes for individuals and healthcare systems. Every platform created by Q2i underscores their understanding of the challenges present in real-world clinical and public-sector environments, especially the difficulty of maintaining long term participation in evidence-based programmes.Founded in Boston in 2016, Q2i aligns its mission with the Institute for Healthcare Improvement Quadruple Aim, striving to enhance patient experience, elevate population health, reduce per-capita costs and improve the working lives of clinicians.
 
Across the United States, Q2i technology now supports multiple statewide behavioural health and public sector initiatives. Thousands of individuals each year rely on these systems during addiction treatment, recovery support, community reentry and chronic-disease prevention programmes. The platforms integrate smoothly into existing clinical workflows, reducing friction for providers and administrators while expanding access for patients. Robust privacy protections, advanced security architecture and strict compliance frameworks ensure that sensitive information remains safeguarded at every step. By translating behavioural science into accessible digital interactions, the platforms help people remain connected to care plans even during demanding periods of life.
 
The judging panel was particularly impressed by the rigorous scientific foundation that supports the important work taking place at Q2i. The company’s platforms draw upon research funded by the National Institutes of Health and on peer-reviewed studies exploring digital contingency management and behavioural reinforcement strategies. These academic roots provide credibility and structure, ensuring that each solution rests upon validated principles rather than fleeting trends. Issued and pending patents protect secure and scalable methods for delivering engagement and adherence support, enabling Q2i to operate confidently within highly regulated environments.

Website: www.q2i-group.com